(Q39201227)

English

Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins

scientific article published on May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins (English)

1 reference

Europe PubMed Central

9 September 2017

1 reference

ChEBI release 2020-05-28

author name string

Lan Yang

1

1 reference

Europe PubMed Central

9 September 2017

Qiong Wang

2

1 reference

Europe PubMed Central

9 September 2017

Daoxia Li

3

1 reference

Europe PubMed Central

9 September 2017

Yuqiong Zhou

4

1 reference

Europe PubMed Central

9 September 2017

Xuelian Zheng

5

1 reference

Europe PubMed Central

9 September 2017

Hong Sun

6

1 reference

Europe PubMed Central

9 September 2017

Jiaqi Yan

7

1 reference

Europe PubMed Central

9 September 2017

Lin Zhang

8

1 reference

Europe PubMed Central

9 September 2017

Yong Lin

9

1 reference

Europe PubMed Central

9 September 2017

Xia Wang

10

1 reference

Europe PubMed Central

9 September 2017

publication date

1 May 2013

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

18

1 reference

Europe PubMed Central

9 September 2017

5

1 reference

Europe PubMed Central

9 September 2017

618-626

1 reference

Europe PubMed Central

9 September 2017

https://scigraph.springernature.com/pub.10.1007/s10495-013-0808-8

0 references

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0808-8

21 January 2018

Identifiers

10.1007/S10495-013-0808-8

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39201227&oldid=1812809773"